A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

NCT03677648 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: SHR0302
DRUG: Placebos

Sponsor

Reistone Biopharma Company Limited